Ondine Biomedical Inc. (OBI.L)
GBp 8.13
(4.84%)
GBp 8.13
(4.84%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -14.8 Million CAD | 21.09% |
| 2022 | -18.76 Million CAD | -7.09% |
| 2021 | -17.52 Million CAD | -10.39% |
| 2020 | -15.87 Million CAD | -13.14% |
| 2019 | -14.02 Million CAD | 15.15% |
| 2018 | -16.53 Million CAD | -186.22% |
| 2017 | -5.77 Million CAD | 0.0% |
| 2010 | -4.18 Million CAD | 9.6% |
| 2009 | -4.62 Million CAD | 54.16% |
| 2008 | -10.08 Million CAD | 23.68% |
| 2007 | -13.21 Million CAD | -7.39% |
| 2006 | -12.3 Million CAD | -38.69% |
| 2005 | -8.87 Million CAD | 0.0% |
| 2003 | -82.95 Thousand CAD | 94.63% |
| 2002 | -1.54 Million CAD | -1961.51% |
| 2001 | -74.94 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.55 Million GBP | 0.0% |
| 2023 Q2 | -4.83 Million GBP | 0.0% |
| 2023 Q4 | -4 Million GBP | 0.0% |
| 2023 FY | -14.8 Million CAD | 21.09% |
| 2022 FY | -18.76 Million CAD | -7.09% |
| 2022 Q2 | -5.09 Million GBP | 0.0% |
| 2022 Q4 | -7.47 Million GBP | 0.0% |
| 2021 FY | -17.52 Million CAD | -10.39% |
| 2020 FY | -15.87 Million CAD | -13.14% |
| 2019 FY | -14.02 Million CAD | 15.15% |
| 2018 FY | -16.53 Million CAD | -186.22% |
| 2017 FY | -5.77 Million CAD | 0.0% |
| 2011 Q1 | -996.79 Thousand CAD | -6.15% |
| 2011 Q2 | -1.31 Million CAD | -31.86% |
| 2010 Q2 | -1.17 Million CAD | 3.87% |
| 2010 FY | -4.18 Million CAD | 9.6% |
| 2010 Q1 | -1.22 Million CAD | -21.83% |
| 2010 Q4 | -939.02 Thousand CAD | -4.03% |
| 2010 Q3 | -902.67 Thousand CAD | 23.36% |
| 2009 Q4 | -1 Million CAD | -148.2% |
| 2009 FY | -4.62 Million CAD | 54.16% |
| 2009 Q1 | -1.45 Million CAD | 26.74% |
| 2009 Q2 | -1.75 Million CAD | -20.41% |
| 2009 Q3 | -405.15 Thousand CAD | 76.92% |
| 2008 Q1 | -2.56 Million CAD | 5.98% |
| 2008 FY | -10.08 Million CAD | 23.68% |
| 2008 Q3 | -3.05 Million CAD | -23.03% |
| 2008 Q4 | -1.98 Million CAD | 34.82% |
| 2008 Q2 | -2.48 Million CAD | 3.2% |
| 2007 Q3 | -3.14 Million CAD | 17.01% |
| 2007 FY | -13.21 Million CAD | -7.39% |
| 2007 Q4 | -2.72 Million CAD | 13.23% |
| 2007 Q1 | -3.56 Million CAD | 0.38% |
| 2007 Q2 | -3.78 Million CAD | -6.28% |
| 2006 Q3 | -2.81 Million CAD | 5.7% |
| 2006 FY | -12.3 Million CAD | -38.69% |
| 2006 Q4 | -3.57 Million CAD | -27.21% |
| 2006 Q2 | -2.98 Million CAD | -1.4% |
| 2006 Q1 | -2.94 Million CAD | -20.56% |
| 2005 FY | -8.87 Million CAD | 0.0% |
| 2005 Q1 | -1.87 Million CAD | -173.29% |
| 2005 Q2 | -2.35 Million CAD | -25.41% |
| 2005 Q3 | -2.21 Million CAD | 5.93% |
| 2005 Q4 | -2.43 Million CAD | -10.29% |
| 2004 Q3 | -1.56 Million CAD | -22.53% |
| 2004 Q4 | -685.86 Thousand CAD | 56.12% |
| 2004 Q2 | -1.27 Million CAD | 28.45% |
| 2004 Q1 | -1.78 Million CAD | -3587.3% |
| 2003 FY | -82.95 Thousand CAD | 94.63% |
| 2003 Q1 | -20.16 Thousand CAD | -1159.4% |
| 2003 Q4 | -48.34 Thousand CAD | -41.01% |
| 2003 Q3 | -34.28 Thousand CAD | -27.42% |
| 2003 Q2 | -26.9 Thousand CAD | -33.44% |
| 2002 Q1 | -14.16 Thousand CAD | 41.17% |
| 2002 Q3 | -1.48 Million CAD | -6299.67% |
| 2002 Q4 | -1601.00 CAD | 99.89% |
| 2002 FY | -1.54 Million CAD | -1961.51% |
| 2002 Q2 | -23.18 Thousand CAD | -63.65% |
| 2001 Q4 | -24.07 Thousand CAD | 0.0% |
| 2001 FY | -74.94 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|